Researchers evaluated the efficacy of secukinumab plus a glucocorticoid taper for achieving sustained remission in polymyalgia rheumatica.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results